New York State Common Retirement Fund’s Exagen XGN Stock Holding History

New York State Common Retirement Fund’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-97	Closed	-$1K	–	3466
2022 Q2	$1K	Sell	97 -6,800	-99%	-$39.6K	﹤0.01%	3422
2022 Q1	$55K	Hold	6,897	–	–	﹤0.01%	3149
2021 Q4	$80K	Sell	6,897 -26	-0.4%	-$305	﹤0.01%	3137
2021 Q3	$94K	Sell	6,923 -4,016	-37%	-$53.4K	﹤0.01%	3161
2021 Q2	$164K	Buy	10,939 +6,339	+138%	+$97.2K	﹤0.01%	3107
2021 Q1	$81K	Hold	4,600	–	–	﹤0.01%	3122
2020 Q4	$61K	Hold	4,600	–	–	﹤0.01%	3161
2020 Q3	$50K	Hold	4,600	–	–	﹤0.01%	3140
2020 Q2	$57K	Hold	4,600	–	–	﹤0.01%	3140
2020 Q1	$73K	Hold	4,600	–	–	﹤0.01%	2875
2019 Q4	$117K	Buy	+4,600	New	+$81.8K	﹤0.01%	2962

Other funds holding XGN

Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

New York State Common Retirement Fund's XGN Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Exagen (XGN) in Q3 2022, closing a stake of 97 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in XGN in Q4 2019 and held it in 11 quarters. The position peaked at $164K in Q2 2021. 38 funds tracked by Wall St. Rank hold XGN as of Q3 2022.

New York State Common Retirement Fund reported no remaining Exagen position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 97 Exagen shares in Q3 2022, an estimated $1K.
New York State Common Retirement Fund first reported a position in Exagen in Q4 2019 and held it in 11 quarters.
New York State Common Retirement Fund's Exagen position peaked at $164K in Q2 2021.
38 funds tracked by Wall St. Rank held Exagen as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.